Radiation Oncology·Phoenix, AZ

Mayo Clinic College of Medicine and Science (Phoenix)

Signal lift60%78%+18 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
229–262
p10 – p90
Sample N
140
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.7%
1 of 34 applicants
01Cohort funnelthis cycle
N = 140
Applied
140
100.0%
Invited
34
24.3%
Class size
1
0.7%
J-1 visaH-1B visaF-1 visaCategorical
Your fitMayo Clinic College of Medicine and Science (Phoenix) Program

Create a free profile to see your personalized fit

Get started
Contact
LM
Program Director
Lisa Mcgee, MD
Email director
HW
Program Coordinator
Heather Wilson, MD
Email coordinator
Training sites4 hospitals
  • 1
    Mayo Clinic College of Medicine and Science
    Rochester, MN
    Primary
  • 2
    Banner University Medical Center-Phoenix
    Phoenix, AZ
    Participant
  • 3
    Mayo Clinic (Arizona)
    Scottsdale, AZ
    Participant
  • 4
    Mayo Clinic Hospital (Arizona)
    Phoenix, AZ
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK229262
180205230255280

Level 2 CE data not available

Interview rates
US MD
34%
US DO
8%
US IMG
14%
Non-US IMG
15%
Applicant origin
In-state
67%
Out-of-state
23%
Interview prepRadiation Oncology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesRadiation Oncology · 25-26
Save this program

Add Mayo Clinic College of Medicine and Science (Phoenix) to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Radiation Oncology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.